Arthur Kuan - Jan 24, 2024 Form 3 Insider Report for CG Oncology, Inc. (CGON)

Role
Chief Executive Officer, Director
Signature
/s/ Corleen Roche, Attorney-in-Fact for Arthur Kuan
Stock symbol
CGON
Transactions as of
Jan 24, 2024
Transactions value $
$0
Form type
3
Date filed
1/24/2024, 09:05 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CGON Common Stock 36.2K Jan 24, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CGON Stock Option Jan 24, 2024 Common Stock 167K $1.72 Direct F1
holding CGON Stock Option Jan 24, 2024 Common Stock 298K $2.29 Direct F2
holding CGON Stock Option Jan 24, 2024 Common Stock 524K $6.68 Direct F3
holding CGON Stock Option Jan 24, 2024 Common Stock 83.9K $12.59 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is currently vested and exercisable.
F2 The stock option vests in 35 substantially equal monthly installments beginning on December 19, 2023.
F3 The stock option vests in 48 substantially equal monthly installments beginning on October 20, 2023.
F4 The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2024.

Remarks:

Exhibit 24 - Power of Attorney.